Real-world effectiveness and safety of Sofos- buvir(SOF)-based therapy in patients with chronic hepatitis C virus infection.
Phase of Trial: Phase IV
Latest Information Update: 15 Nov 2017
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 15 Nov 2017 New trial record
- 24 Oct 2017 Results presented at The Liver Meeting 2017: 68th Annual Meeting of the American Association for the Study of Liver Diseases.